Publication:
Comparative Efficacy of First-Line Natalizumab Versus IFNb or Glatiramer Acetate in Relapsing MS

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Kubala Havrdova, Eva/0000-0002-9543-4359; Horáková, Dana/0000-0003-1915-0036

Keywords

Citation

WoS Q

Q1

Scopus Q

Q1

Source

Multiple Sclerosis Journal

Volume

21

Issue

Start Page

258

End Page

259

Endorsement

Review

Supplemented By

Referenced By